Hepatitis C

Medicare spending $9B on hepatitis C drugs
Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to new government figures. That's raising insurance costs for all beneficiaries, whether or not they have the liver-wasting viral disease.
Hepatitis C Drug Approved by FDA Panel
An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government advisers who say the medication should be approved to treat patients infected with the liver-destroying virus.
NH Tech in Hepatitis Outbreak to Plead
A traveling hospital technician accused of infecting dozens of patients with hepatitis C through tainted needles told investigators he had been stealing drugs for more than a decade and was "killing a lot of people," according to a plea agreement filed Monday that would send him to…